Cited by 495Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.

Laboratory diagnosis of invasive aspergillosis

Open access

Hope, WW, Walsh, TJ, Denning, DW·2005·The Lancet Infectious Diseases

Open this paper in CoChat — free account

Abstract

Invasive aspergillosis occurs in a wide range of clinical scenarios, is protean in its manifestations, and is still associated with an unacceptably high mortality rate. Early diagnosis is critical to a favourable outcome, but is difficult to achieve with current methods. Deep tissue diagnostic specimens are often difficult to obtain from critically ill patients. Newer antifungal agents exhibit differential mould activity, thus increasing the importance of establishing a specific diagnosis of invasive aspergillosis. For these reasons, a range of alternate diagnostic strategies have been investigated. Most investigative efforts have focused on molecular and serological diagnostic techniques. The detection of metabolites produced by Aspergillus spp and a range of aspergillus-specific antibodies represent additional, but relatively underused, diagnostic avenues. The detection of galactomannan has been incorporated into diagnostic criteria for invasive aspergillosis, reflecting an increased understanding of the performance, utility, and limitations of this technique. Measurement of (1,3)-beta-D glucan in blood may be useful as a preliminary screening tool for invasive aspergillosis, despite the fact that this antigen can be detected in a number of other fungi. There have been extensive efforts directed toward the detection of Aspergillus spp DNA, but a lack of technical standardisation and relatively poor understanding of DNA release and kinetics continues to hamper the broad applicability of this technique. This review considers the application, utility, and limitations of the currently available and investigational diagnostic modalities for invasive aspergillosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(05)70238-3

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citation
Manual of clinical microbiology
Drasar, B. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90074-5 · Cited by 2,605
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citation
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Atlas of Clinical Fungi
de Hoog, S., Guarro, J., Gené, J., & Figueras, M. J. (2000) · UvA-DARE (University of Amsterdam) · Cited by 1,427
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nierman, W. C., Pain, A., Anderson, M. J., Wortman, J. R., Kim, H. S., Arroyo, J., Berriman, M., Abe, K., Archer, D. B., Bermejo, C., et al. (2005) · Nature · doi:10.1038/nature04332 · Cited by 1,391
Self-citation
Bronchoalveolar lavage
Mitchell, D., Wells, A. U., Spiro, S. G., & Moller, D. (2012) · CRC Press eBooks · doi:10.1201/b13322-18 · Cited by 828
Epidemiology of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Odabaşı, Z., Mattiuzzi, G. N., Estey, E., Kantarjian, H. M., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M., Rex, J. H., & Ostrosky‐Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 641

Show all 137 references

Sorted by citations

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citation
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citation
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citation
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738
Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., RAAD, I. I., Rolston, K. V. I., Young, J. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 714
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J. W., Stark, P., Durand, C. M., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 589
Self-citation
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Galactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Bulpa, P., Dive, A., & Sibille, Y. (2007) · European Respiratory Journal · doi:10.1183/09031936.00062206 · Cited by 470
Invasive aspergillosis in the intensive care unit
Meersseman, W., Lagrou, K., Maertens, J., & Wijngaerden, E. V. (2007) · Clinical Infectious Diseases · doi:10.1086/518852 · Cited by 366
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Leeflang, M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J. P. M., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., & Vandenbroucke‐Grauls, C. M. J. E. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394 · Cited by 364
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
Mengoli, C., Cruciani, M., Barnes, R. A., Loeffler, J., & Donnelly, J. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70019-2 · Cited by 354
High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Self-citation
Aspergillus PCR: One Step Closer to Standardization
White, P. L., Bretagne, S., Klingspor, L., Melchers, W. J. G., McCulloch, E., Schulz, B., Finnstrom, N., Mengoli, C., Barnes, R. A., Donnelly, J. P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01767-09 · Cited by 296
Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus
Mowat, E., Butcher, J., Lang, S., Williams, C., & Ramage, G. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47247-0 · Cited by 259
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
Maertens, J. A., Maertens, V., Theunissen, K., Meersseman, W., Meersseman, P., Meers, S., Verbeken, E. K., Verhoef, G. E. G., Eldere, J. V., & Lagrou, K. (2009) · Clinical Infectious Diseases · doi:10.1086/647935 · Cited by 250
Patients at High Risk of Invasive Fungal Infections
Rüping, M. J. G. T., Vehreschild, J. J., & Cornely, O. A. (2008) · Drugs · doi:10.2165/00003495-200868140-00002 · Cited by 250
Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients
Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B. J., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D. C., Baz, M. A., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00077-07 · Cited by 230
Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis
Zou, M., Tang, L., Zhao, S., Zhao, Z., Chen, L., Chen, P., Huang, Z., Li, J., Chen, L., & Fan, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043347 · Cited by 227
Galactomannan detection for invasive aspergillosis in immunocompromised patients
Leeflang, M., Debets-Ossenkopp, Y. J., Wang, J., Visser, C. E., Scholten, R. J. P. M., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Zhang, M., Bossuyt, P. M., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394.pub2 · Cited by 228
Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis
Westh, H., Lisby, G., Breysse, F., Böddinghaus, B., Chomarat, M., Gant, V. A., Goglio, A., Raglio, A., Schuster, H., Stüber, F., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02736.x · Cited by 224
Novel immunologic classification of aspergillosis in adult cystic fibrosis
Baxter, C. G., Dunn, G., Jones, A. M., Webb, A. K., Gore, R. B., Richardson, M. D., & Denning, D. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.007 · Cited by 213
Self-citation
Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment
Barnes, P. D., & Marr, K. A. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.001 · Cited by 205
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis
Guo, Y., Chen, Y., Wang, K., Qin, S., Wu, C., & Kong, J. (2010) · CHEST Journal · doi:10.1378/chest.10-0488 · Cited by 197
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity
D'Haese, J., Theunissen, K., Vermeulen, E., Schoemans, H., De Vlieger, G., Lammertijn, L., Meersseman, P., Meersseman, W., Lagrou, K., & Maertens, J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06423-11 · Cited by 186
Utility of Galactomannan Enzyme Immunoassay and (1,3) β- d -Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
Hachem, R. Y., Kontoyiannis, D. P., Chemaly, R. F., Jiang, Y., Reitzel, R. A., & RAAD, I. I. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00506-08 · Cited by 184
Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme Immunoassay
Maertens, J. A., Klont, R., Masson, C., Theunissen, K., Meersseman, W., Lagrou, K., Heinen, C., Crepin, B., Eldere, J. V., Tabouret, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514349 · Cited by 182
Review of Fungal Outbreaks and Infection Prevention in Healthcare Settings During Construction and Renovation
Kanamori, H., Rutala, W. A., Sickbert-Bennett, E. E., & Weber, D. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ297 · Cited by 179
Invasive Mycoses: Diagnostic Challenges
Ostrosky‐Zeichner, L. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.008 · Cited by 178
Invasive Fungal Infections in Solid Organ Transplant Recipients
Shoham, S., & Marr, K. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.28 · Cited by 176
Contribution of the (1→3)-β- d -Glucan Assay for Diagnosis of Invasive Fungal Infections
Persat, F., Ranque, S., Derouin, F., Michel-Nguyen, A., Picot, S., & Sulahian, A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02091-07 · Cited by 173
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections
Hot, A., Maunoury, C., Poirée, S., Lanternier, F., Viard, J., Loulergue, P., Coignard-Biehler, H., Bougnoux, M., Suárez, F., Rubio, M., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03301.x · Cited by 162
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Koo, S., Thomas, H. R., Daniels, S. D., Lynch, R. C., Fortier, S. M., Shea, M. M., Rearden, P., Comolli, J. C., Baden, L. R., & Marty, F. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu725 · Cited by 153
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
Barnes, P. D., & Marr, K. A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06812.x · Cited by 151
Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
Trof, R. J., Beishuizen, A., Debets-Ossenkopp, Y. J., Girbes, A. R. J., & Groeneveld, A. B. J. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0791-z · Cited by 144
Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay
Wheat, L. J., & Walsh, T. J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0437-7 · Cited by 138
Self-citation
ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo
Rolle, A.-M., Hasenberg, M., Thornton, C. R., Solouk-Saran, D., Männ, L., Weski, J., Maurer, A., Fischer, E., Spycher, P. R., Schibli, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518836113 · Cited by 134
Diagnosis of Invasive Aspergillosis by a Commercial Real-Time PCR Assay for Aspergillus DNA in Bronchoalveolar Lavage Fluid Samples from High-Risk Patients Compared to a Galactomannan Enzyme Immunoassay
Torelli, R., Sanguinetti, M., Moody, A., Pagano, L., Caira, M., Carolis, E. D., Fuso, L., PASCALE, G. D., Bello, G., Antonelli, M. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05026-11 · Cited by 133
The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?
Mowat, E., Williams, C., Jones, B., Mcchlery, S., & Ramage, G. (2009) · Medical Mycology · doi:10.1080/13693780802238834 · Cited by 131
The case for antifungal stewardship
Ananda-Rajah, M. R., Slavin, M. A., & Thursky, K. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e0680 · Cited by 128
Diagnosis of Histoplasmosis by Antigen Detection in BAL Fluid
Hage, C. A., Davis, T. E., Fuller, D., Egan, L., Witt, J. R., Wheat, L. J., & Knox, K. S. (2009) · CHEST Journal · doi:10.1378/chest.09-1702 · Cited by 128
Pathogenesis of Aspergillus fumigatus and the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy
Hope, W. W., Kruhlak, M. J., Lyman, C. A., Petraitienė, R., Petraitis, V., Francesconi, A., Kasai, M., Mickiene, D., Sein, T., Peter, J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/510535 · Cited by 128
Self-citation
68Ga-Siderophores for PET Imaging of Invasive Pulmonary Aspergillosis: Proof of Principle
Petřík, M., Haas, H., Dobrozemsky, G., Lass‐Flörl, C., Helbok, A., Blatzer, M., Dietrich, H., & Decristoforo, C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.072462 · Cited by 128
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients
Maertens, J. A., Buvé, K., Theunissen, K., Meersseman, W., Verbeken, E. K., Verhoef, G. E. G., Eldere, J. V., & Lagrou, K. (2008) · Cancer · doi:10.1002/cncr.24022 · Cited by 127
Therapeutic Drug Monitoring of Voriconazole
Brüggemann, R. J. M., Donnelly, J. P., Aarnoutse, R. E., Warris, A., Blijlevens, N. M. A., Mouton, J. W., Verweij, P. E., & Burger, D. M. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31817b1a95 · Cited by 125
Use and Limits of (1-3)-β- d -Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis
Sulahian, A., Porcher, R., Bergeron, A., Touratier, S., Raffoux, E., Ménotti, J., Derouin, F., & Ribaud, P. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03567-13 · Cited by 124
Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
Petřík, M., Franssen, G. M., Haas, H., Laverman, P., Hörtnagl, C., Schrettl, M., Helbok, A., Lass‐Flörl, C., & Decristoforo, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2110-3 · Cited by 123
Overcoming antifungal resistance
Srinivasan, A., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2014) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2014.02.005 · Cited by 123
Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay
Cummings, J. R., Jamison, G. R., Boudreaux, J. W., Howles, M. J., Walsh, T. J., & Hayden, R. T. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.04.022 · Cited by 116
Self-citation
Revisión sistemática de las publicaciones sobre diagnóstico de la aspergilosis invasora mediante reacción en cadena de la polimerasa (PCR) de lavados bronco-alveolares
Tuon, F. F. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70020-7 · Cited by 116
Antibody testing in aspergillosis—quo vadis?
Page, I. D., Richardson, M. D., & Denning, D. W. (2015) · Medical Mycology · doi:10.1093/mmy/myv020 · Cited by 112
Self-citation
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
Koo, S., Porter, J., Baden, L. R., & Marty, F. M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02281-09 · Cited by 103
Fungal Infections of the CNS
Black, K. E., & Baden, L. R. (2007) · CNS Drugs · doi:10.2165/00023210-200721040-00004 · Cited by 101
Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
Nucci, M., Carlesse, F. A. D. M. C., Cappellano, P., Varon, A. G., Seber, A., Garnica, M. M., Nouér, S. A., & Colombo, A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087784 · Cited by 99
Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000–2013
Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw268 · Cited by 98
Aspergillus to Zygomycetes: Causes, Risk Factors, Prevention, and Treatment of Invasive Fungal Infections
Cornely, O. A. (2008) · Infection · doi:10.1007/s15010-008-7357-z · Cited by 98
Use of Bronchoalveolar Lavage To Detect Galactomannan for Diagnosis of Pulmonary Aspergillosis among Nonimmunocompromised Hosts
Nguyen, M. H., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B. J., Wheat, L. J., Cline, C. L., Baz, M. A., Rand, K. H., & Clancy, C. J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00716-07 · Cited by 97
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho‐Montero, J., Olaechea, P., Álvarez-Lerma, F., Álvarez-Rocha, L., Blanquer, J., Galván, B., Rodríguez, A. H., Zaragoza, R., Aguado, J. M., Mensa, J., et al. (2013) · PubMed · Cited by 97
Insights into fungal communities in composts revealed by 454-pyrosequencing: implications for human health and safety
de Gannes, V., Eudoxie, G. D., & Hickey, W. J. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00164 · Cited by 96
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
Mortensen, K. L., Johansen, H. K., Fuursted, K., Knudsen, J. D., Gahrn-Hansen, B., Jensen, R. H., Howard, S. J., & Arendrup, M. C. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1229-7 · Cited by 92
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people
Cruciani, M., Mengoli, C., Loeffler, J., Donnelly, P., Barnes, R. A., Jones, B. L., Klingspor, L., Morton, C. O., & Maertens, J. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009551.pub3 · Cited by 91
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum
Vergidis, P., Moore, C. B., Frazer, L. N., Rautemaa‐Richardson, R., Walker, A., Denning, D. W., & Richardson, M. D. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.019 · Cited by 90
Self-citation
Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Cross-Reactivity Caused by Invasive Geotrichum capitatum
Giacchino, M., Chiapello, N., Bezzio, S., Fagioli, F., Saracco, P., Alfarano, A., Martini, V., Cimino, G. G., Martino, P., & Girmenia, C. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00856-06 · Cited by 90
Proteome Profiling and Functional Classification of Intracellular Proteins from Conidia of the Human-Pathogenic Mold Aspergillus fumigatus
Teutschbein, J., Albrecht, D., Pötsch, M., Guthke, R., Aimanianda, V., Clavaud, C., Latgé, J., Brakhage, A. A., & Kniemeyer, O. (2010) · Journal of Proteome Research · doi:10.1021/pr9010684 · Cited by 89
Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
de Heer, K., Gerritsen, M. G., Visser, C. E., & Leeflang, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012399.pub2 · Cited by 89
Distinct Innate Immune Phagocyte Responses to Aspergillus fumigatus Conidia and Hyphae in Zebrafish Larvae
Knox, B. P., Deng, Q., Rood, M., Eickhoff, J. C., Keller, N. P., & Huttenlocher, A. (2014) · Eukaryotic Cell · doi:10.1128/ec.00080-14 · Cited by 92
Evaluation of PCR on Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Aspergillosis: A Bivariate Metaanalysis and Systematic Review
Sun, W., Wang, K., Gao, W., Su, X., Qian, Q., Lu, X., Song, Y., Guo, Y., & Shi, Y. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028467 · Cited by 86
Pneumonia in the neutropenic cancer patient
Evans, S. E., & Ost, D. E. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000156 · Cited by 84
Molecular Detection and Species-Specific Identification of Medically Important Aspergillus Species by Real-Time PCR in Experimental Invasive Pulmonary Aspergillosis
Walsh, T. J., Wissel, M., Grantham, K. J., Petraitienė, R., Petraitis, V., Kasai, M., Francesconi, A., Cotton, M. P., Hughes, J. E., Greene, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00570-11 · Cited by 84
Self-citation
Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of A spergillus quantitative PCR
Fraczek, M. G., Kirwan, M., Moore, C. B., Morris, J., Denning, D. W., & Richardson, M. D. (2013) · Mycoses · doi:10.1111/myc.12103 · Cited by 83
Self-citation
Combined real‐time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies
Rogers, T. R., Morton, C. O., Springer, J., Conneally, E., Heinz, W., Kenny, C. C., Frost, S., Einsele, H., & Loeffler, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12285 · Cited by 79
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people
Cruciani, M., Mengoli, C., Barnes, R. A., Donnelly, J. P., Loeffler, J., Jones, B. L., Klingspor, L., Maertens, J. A., Morton, C. O., & White, L. P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009551.pub4 · Cited by 80
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
Maertens, J. A., Theunissen, K., Lodewyck, T., Lagrou, K., & Eldere, J. V. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01375.x · Cited by 78
Fungal infections in adult patients on extracorporeal life support
Cavayas, Y. A., Yusuff, H. O., & Porter, R. (2018) · Critical Care · doi:10.1186/s13054-018-2023-z · Cited by 80
A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d-glucan chromogenic assay in serum samples
Acosta, J., Catalán, M., del Palacio‐Pérez‐Medel, Á., Lora, D., Montejo, J. C., Cuétara, M. S., Moragues, M. D., Pontón, J., & del Palacio, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03357.x · Cited by 77
Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis
Francesconi, A., Kasai, M., Petraitienė, R., Petraitis, V., Kelaher, A. M., Schaufele, R. L., Hope, W. W., M.S., Y. R. S., Bacher, J. D., & Walsh, T. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02693-05 · Cited by 76
Self-citation
Aspergillosis in Chronic Granulomatous Disease
King, J., Henriet, S., & Warris, A. (2016) · Journal of Fungi · doi:10.3390/jof2020015 · Cited by 76
Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients
Bergeron, A., Porcher, R., Ménotti, J., POIROT, J. L., Chagnon, K., Vekhoff, A., Cornet, M., Isnard, F., Raffoux, E., Brethon, B., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00750-11 · Cited by 75
In Vitro Release by Aspergillus fumigatus of Galactofuranose Antigens, 1,3-β- d -Glucan, and DNA, Surrogate Markers Used for Diagnosis of Invasive Aspergillosis
Mennink‐Kersten, M. A. S. H., Ruegebrink, D., Wasei, N., Melchers, W. J. G., & Verweij, P. E. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1711-1718.2006 · Cited by 75
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
Hayden, R. T., Pounds, S. B., Knapp, K. M., Petraitienė, R., Schaufele, R. L., Sein, T., & Walsh, T. J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817197ab · Cited by 74
Self-citation
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis
Maertens, J. A., & Miceli, M. H. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1562892 · Cited by 75
Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis
Aquino, V. R., Goldani, L. Z., & Pasqualotto, A. C. (2007) · Mycopathologia · doi:10.1007/s11046-007-9010-2 · Cited by 73
Current Status and Future Perspectives on Molecular and Serological Methods in Diagnostic Mycology
Lau, A. F., Chen, W., Sleiman, S., & Sorrell, T. C. (2009) · Future Microbiology · doi:10.2217/fmb.09.70 · Cited by 74
Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit
Dannaoui, É., Gabriel, F., Gaboyard, M., Lagardere, G., Audebert, L., Quesne, G., Godichaud, S., Verweij, P. E., Accoceberry, I., & Bougnoux, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01032-17 · Cited by 72
New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies
Patterson, T. F., & Donnelly, J. P. (2019) · Journal of Fungi · doi:10.3390/jof5010009 · Cited by 72
Two‐dimensional proteome reference maps for the human pathogenic filamentous fungus Aspergillus fumigatus
Vödisch, M., Albrecht, D., Leßing, F., Schmidt, A. D., Winkler, R., Guthke, R., Brakhage, A. A., & Kniemeyer, O. (2009) · PROTEOMICS · doi:10.1002/pmic.200800394 · Cited by 71
Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus
Schütte, M., Thullier, P., Pelat, T., Wezler, X., Rosenstock, P., Hinz, D., Kirsch, M. I., Hasenberg, M., Frank, R., Schirrmann, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006625 · Cited by 70
MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin
CHIERICO, F. D., Masotti, A., Onori, M., Fiscarelli, E. V., Mancinelli, L., Ricciotti, G., Alghisi, F., Dimiziani, L., Manetti, C., Urbani, A., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.048 · Cited by 69
Primary antifungal prophylaxis in leukaemia patients
Maertens, J. A., Frère, P., Lass‐Flörl, C., Heinz, W., & Cornely, O. A. (2007) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2007.06.006 · Cited by 68
Evaluation of MycAssay™ Aspergillus for Diagnosis of Invasive Pulmonary Aspergillosis in Patients without Hematological Cancer
Guinea, J., Padilla, C., Escribano, P., Muñóz, P., Padilla, B., Gijón, P., & Bouza, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061545 · Cited by 67
Approaches to the Management of Invasive Fungal Infections in Hematologic Malignancy and Hematopoietic Cell Transplantation
Michallet, M., & Ito, J. I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1178 · Cited by 64
Diagnosis of invasive pulmonary aspergillosis: Updates and recommendations
Désoubeaux, G., Bailly, É., & Chandenier, J. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.11.006 · Cited by 69
Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Ruíz-Camps, I., Aguado, J. M., Almirante, B., Bouza, E., Ferrer, C., Len, Ó., López‐Cerero, L., Rodríguez-Tudela, J. L., Ruiz, M. S., Solé, A., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03477.x · Cited by 66
Neutrophil Interactions Stimulate Evasive Hyphal Branching by Aspergillus fumigatus
Ellett, F. E., Jorgensen, J. A., Frydman, G. H., Jones, C. N., & Irimia, D. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006154 · Cited by 63
Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients
Fortün, J., Martín‐Dávila, P., de la Pedrosa, E. G. G., Silva, J. T., García‐Rodríguez, J., Benito, D., Rullo, E. V., Castaño, F., Fernández‐Ruiz, M., Lázaro, F., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.02.019 · Cited by 62
Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009–2013
Zilberberg, M. D., Nathanson, B. H., Harrington, R. L., Spalding, J. R., & Shorr, A. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy181 · Cited by 60
Risk Factors Associated With Invasive Fungal Disease in Children With Cancer and Febrile Neutropenia
Milena Villarroel, C., Avilés, C. L., Silva, P., Guzmán, A. M., Helena Poggi, M., Alvarez, A., Becker, A., O’Ryan, M., Salgado, C., Topelberg, S., V, et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181e7db7f · Cited by 58

Authors: Hope, W., Walsh, T., & Denning, D.
Affiliations: National Institutes of Health (US)
Venue: The Lancet Infectious Diseases
Publisher: Elsevier BV
Published: 2005-10
Volume: 5
Issue: 10
Pages: 609-622
ISSN: 1473-3099 (ISSN-L)
DOI: 10.1016/s1473-3099(05)70238-3
OpenAlex: W2066421491
Cited by: 495
References: 137
Citations by year: 2026: 9 · 2025: 10 · 2024: 12 · 2023: 12 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 21 · 2018: 15 · 2017: 23 · 2016: 30 · 2015: 36 · 2014: 23 · 2013: 30 · 2012: 33
FWCI: 4.42
Type: journal article
Language: en
Open access: green
research.manchester.ac.uk
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords: invasive aspergillosis, Aspergillus, laboratory diagnosis, galactomannan, β-1,3-glucan, molecular diagnosis, serological diagnosis, fungal DNA detection, critically ill patients
MeSH terms: Antibodies, Fungal, Aspergillosis, Aspergillus, DNA, Fungal, Galactose, Humans, Mannans, Clinical Laboratory Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Laboratory diagnosis of invasive aspergillosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks